The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Does Locoregional Radiation Therapy Improve Survival in Breast Cancer? A Meta-Analysis
Abstract
PURPOSE: Recent randomized trials in women with node-positive breast cancer who received systemic treatment report that locoregional radiation therapy improves survival. Previous trials failed to detect a difference in survival that results from its use. A systematic review of randomized trials that examine the effectiveness of locoregional radiation therapy in patients treated by definitive surgery and adjuvant systemic therapy was conducted. METHODS: Randomized trials published between 1967 and 1999 were identified through MEDLINE database, CancerLit database, and reference lists of relevant articles. Relevant data was abstracted. The results of randomized trials were pooled using meta-analyses to estimate the effect of treatment on any recurrence, locoregional recurrence, and mortality. RESULTS: Eighteen trials that involved a total of 6,367 patients were identified. Most trials included both pre- and postmenopausal women with node-positive breast cancer treated with modified radical mastectomy. The type of systemic therapy received, sites irradiated, techniques used, and doses of radiation delivered varied between trials. Data on toxicity were infrequently reported. Radiation was shown to reduce the risk of any recurrence (odds ratio, 0.69; 95% confidence interval [CI], 0.58 to 0.83), local recurrence (odds ratio, 0.25; 95% CI, 0.19 to 0.34), and mortality (odds ratio, 0.83; 95% CI, 0.74 to 0.94). CONCLUSION: Locoregional radiation after surgery in patients treated with systemic therapy reduced mortality. Several questions remain on how these results should be translated into current-day clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Self-citationON ESTIMATING THE RELATION BETWEEN BLOOD GROUP AND DISEASE
WOOLF, B. (1955) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1955.tb01348.x · Cited by 2,723
Overgaard, M., Hansen, P. S., Overgaard, J., Rose, C., Andersson, M., Bach, F., Kjaer, M., Gadeberg, C. C., Mouridsen, H. T., Jensen, M.-B., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710023371401 · Cited by 2,554
Adjuvant Radiotherapy and Chemotherapy in Node-Positive Premenopausal Women with Breast Cancer
Ragaz, J., Jackson, S. M., Le, N., Plenderleith, I. H., Spinelli, J. J., Basco, V. E., Wilson, K. S., Knowling, M. A., Coppin, C. M. L., Paradis, M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710023371402 · Cited by 1,745
Overgaard, M., Jensen, M.-B., Overgaard, J., Hansen, P. S., Rose, C., Andersson, M., Kamby, C., Kjaer, M., Gadeberg, C. C., Rasmussen, B. B., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09201-0 · Cited by 1,602
Effects of Radiotherapy and Surgery in Early Breast Cancer — An Overview of the Randomized Trials
(1995) · New England Journal of Medicine · doi:10.1056/nejm199511303332202 · Cited by 1,012
Cuzick, J., Stewart, H., Rutqvist, L., Houghton, J., Edwards, R., Redmond, C., Peto, R., Baum, M., Fisher, B., & Host, H. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.3.447 · Cited by 889
A random‐effects regression model for meta‐analysis
Berkey, C. S., Hoaglin, D. C., Mosteller, F., & Colditz, G. A. (1995) · Statistics in Medicine · doi:10.1002/sim.4780140406 · Cited by 879
Meta-analysis of the literature or of individual patient data: is there a difference?
Stewart, L. A., & Parmar, M. K. B. (1993) · The Lancet · doi:10.1016/0140-6736(93)93004-k · Cited by 769
Some Statistical Methods for Combining Experimental Results
Laird, N. M., & Mosteller, F. (1990) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300008916 · Cited by 568
Risk of Leukemia after Chemotherapy and Radiation Treatment for Breast Cancer
Curtis, R. E., Boice, J. D., Stovall, M., Bernstein, L., Greenberg, R. S., Flannery, J. T., Schwartz, A. G., Weyer, P., Moloney, W. C., & Hoover, R. N. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206253262605 · Cited by 446
Karnofsky Memorial Lecture. Natural history of small breast cancers.
Hellman, S. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.10.2229 · Cited by 418
Howell, A., Ribeiro, G. G., & Swindell, R. (1995) · Cited by 410
A guide to interpreting discordant systematic reviews.
Jadad, A., Cook, D. J., & Browman, G. P. (1997) · Europe PMC (PubMed Central) · Cited by 399
Self-citationRutqvist, L. E., Lax, I., Fornander, T., & Johansson, H. (1992) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(92)90784-f · Cited by 391
Larson, D., Weinstein, M., Goldberg, I., Silver, B., Recht, A., Cady, B., Silen, W., & Harris, J. R. (1986) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(86)90280-4 · Cited by 374
Tobin, M. B., Lacey, H. J., Meyer, L., & Mortimer, P. S. (1993) · Cancer · doi:10.1002/1097-0142(19931201)72:11<3248::aid-cncr2820721119>3.0.co;2-z · Cited by 353
Overview of Randomized Trials of Postoperative Adjuvant Radiotherapy in Breast Cancer
Cuzick, J., Stewart, H. J., Peto, R., Baum, M., Fisher, B., Host, H., Lythgoe, J. P., Ribeiro, G., Scheurlen, H., & Wallgren, A. (1988) · Recent Results in Cancer Research · doi:10.1007/978-3-642-83419-6_15 · Cited by 308
Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients.
Shapiro, C. L., Hardenbergh, P. H., Gelman, R., Blanks, D., Hauptman, P., Recht, A., Hayes, D. F., Harris, J., & Henderson, I. C. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.11.3493 · Cited by 264
A quality assessment of randomized control trials of primary treatment of breast cancer.
Liberati, A., Himel, H. N., & Chalmers, T. C. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.6.942 · Cited by 195
Haybittle, J. L., Brinkley, D., Houghton, J., A'Hern, R. P., & Baum, M. (1989) · BMJ · doi:10.1136/bmj.298.6688.1611 · Cited by 188
Jones, J. M., & Ribeiro, G. G. (1989) · Clinical Radiology · doi:10.1016/s0009-9260(89)80099-6 · Cited by 165
Griem, K., Henderson, I. C., Gelman, R. S., Dm, A., Silver, B., Recht, A., Goodman, R. L., Hellmän, S., & Harris, J. R. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.10.1546 · Cited by 147
Stopping Metastases at Their Source
Hellmän, S. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710023371408 · Cited by 141
Cardiac doses in post-operative breast irradiation
Fuller, S., Haybittle, J. L., Smith, R. E., et al. (1992) · Radiotherapy and Oncology · doi:10.1016/0167-8140(92)90190-6 · Cited by 123
From Science to Practice: Meta-analyses Using Individual Patient Data Are Needed
Oxman, A. D. (1995) · JAMA · doi:10.1001/jama.1995.03530100085040 · Cited by 113
Vélez-García, E., Carpenter, J. T., Moore, M., Vogel, C. L., Marcial, V. A., Ketcham, A. S., Singh, K. P., Bass, D., Bartolucci, A. A., & Smalley, R. V. (1992) · European Journal of Cancer · doi:10.1016/0959-8049(92)90015-t · Cited by 90
The social, emotional and financial implications of adjuvant chemotherapy in breast cancer
McArdle, C. S., Calman, K. C., Cooper, A., Hughson, A. V. M., Russell, A. R., & Smith, D. C. (1981) · British journal of surgery · doi:10.1002/bjs.1800680413 · Cited by 27
Research works printed but not linked: 24
- 10.1200/JCO.1998.16.8.2886 · doi:10.1200/jco.1998.16.8.2886
- 10.1093/annonc/5.suppl_5.209 · doi:10.1093/annonc/5.suppl_5.209
- 10.1002/1097-0142(19810301)47:5<877::AID-CNCR2820470511>3.0.CO;2-3 · doi:10.1002/1097-0142(19810301)47:5<877::aid-cncr2820470511>3.0.co;2-3
- 10.1056/NEJM199511303332202 · DOI · Paper page
- 10.1056/NEJM199511303332202 · DOI · Paper page
- 10.1002/1097-0142(1984)54:4<670::AID-CNCR2820540414>3.0.CO;2-7 · doi:10.1002/1097-0142(1984)54:4<670::aid-cncr2820540414>3.0.co;2-7
- 10.1002/1097-0142(19870901)60:5<936::AID-CNCR2820600504>3.0.CO;2-P · DOI
- 10.1056/NEJM199511303332202 · DOI · Paper page
- 10.1038/bjc.1992.430 · doi:10.1038/bjc.1992.430
- 10.1002/1097-0142(19810615)47:12<2833::AID-CNCR2820471214>3.0.CO;2-I · doi:10.1002/1097-0142(19810615)47:12<2833::aid-cncr2820471214>3.0.co;2-i
- 10.1007/BF01980937 · doi:10.1007/bf01980937
- Schmoor C, Bastert G, Bojar H, et al: Effect of radiotherapy in addition to 6 cycles CMF in node positive breast cancer patients: German Breast Cancer Study Group (GBSG). Eur J Cancer 34:S59,1998 (suppl 5, abstr) · doi:10.1016/s0959-8049(98)80237-2
- 10.1002/bjs.1800730407 · doi:10.1002/bjs.1800730407
- 10.1007/BF01855128 · doi:10.1007/bf01855128
- 10.1097/00000421-198208000-00005 · doi:10.1097/00000421-198208000-00005
- 10.1016/0360-3016(84)90714-4 · doi:10.1016/0360-3016(84)90714-4
- 10.1002/(SICI)1097-0142(19970315)79:6<1138::AID-CNCR12>3.0.CO;2-0 · doi:10.1002/(sici)1097-0142(19970315)79:6<1138::aid-cncr12>3.0.co;2-0
- 10.3109/02841867909128213 · doi:10.3109/02841867909128213
- 10.3109/02841869209088914 · doi:10.3109/02841869209088914
- 10.3109/02841869309092445 · doi:10.3109/02841869309092445
- 10.1016/0360-3016(90)90214-5 · doi:10.1016/0360-3016(90)90214-5
- 10.3109/02841868809091772 · doi:10.3109/02841868809091772
- 10.1200/JCO.1991.9.9.1662 · doi:10.1200/jco.1991.9.9.1662
- 10.1016/0360-3016(93)90169-V · doi:10.1016/0360-3016(93)90169-v
Cited by
Ragaz, J., Olivotto, I. A., Spinelli, J. J., Phillips, N., Jackson, S. M., Wilson, K. S., Knowling, M. A., Coppin, C. M. L., Weir, L., Gelmon, K., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh297 · Cited by 1,027
Recht, A., Edge, S. B., Solin, L. J., Robinson, D. S., Estabrook, A., Fine, R. E., Fleming, G. F., Formenti, S., Hudis, C., Kirshner, J. J., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1539 · Cited by 816
Self-citationVeronesi, U., Boyle, P., Goldhirsch, A., Orecchia, R., & Viale, G. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66546-4 · Cited by 542
Metadata
- Authors
- Whelan, T. J., Julian, J., Wright, J., Jadad, A. R., & Levine, M. L.
- Venue
- Journal of Clinical Oncology
- Published
- 2000-03-13
- Volume
- 18
- Issue
- 6
- Pages
- 1220-1229
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1857442781
- Cited by
- 507
- References
- 28
- FWCI
- 1.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.